Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer

NCT01804790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

461

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Rectum

Interventions

DRUG: mFolfirinox
RADIATION: Radiotherapy 50 Gy
DRUG: Capecitabine
PROCEDURE: TME surgery
DRUG: mFolfox6 or capecitabine

Sponsor

UNICANCER